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Abstract | This study explores the 
prevalence, predictors and nature of 
the ‘social supply’ of pharmaceutical 
opioids among police detainees.  
Social supply refers to non-commercial 
drug distribution that occurs between 
family and friends. Analysing data 
from the Drug Use Monitoring in 
Australia program’s surveys of police 
detainees, this study finds that more 
than half of the respondents who had 
used pharmaceutical opioids for 
non-medical purposes had accessed 
these drugs through social supply 
methods. Almost all of these 
individuals had sourced the opioids 
from family and friends without paying 
and the remainder had swapped other 
drugs for them. 
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Pharmaceutical opioids are diverted from medical use to 
the black market through various methods, including illicit 
drug dealers, deception of medical professionals and illegal 
prescribing practices. However, research has shown that the 
most common method of pharmaceutical opioid diversion 
is ‘social supply’ (Hough et al. 2003; Potter 2009) or the 
sharing, swapping or other non-commercial supply between 
family members and friends (Hulme, Bright & Nielsen 2018; 
Inciardi et al. 2009; Patterson, Sullivan & Ticehurst 2018). 
While social supply has been defined in different ways, the 
literature identifies two key criteria: (1) supply between 
‘non-strangers’ and (2) ‘non-commercial’ or ‘non-profit’ 
supply (Hough et al. 2003; Potter 2009). Potter (2009) notes 
that supply between non-strangers involves a relationship 
between drug supplier and user beyond the drug-transaction 
connection, often in the form of friendships but also 
including intimate partner, family and close acquaintance 
relationships. Defining the non-commercial or non-profit 
aspect of social supply is problematic because of the nuances 
of drug markets. Potter (2009) makes a distinction between 
dealers motivated by a desire for profit and those who would 
supply drugs even if they would not make a profit—but who 
may still earn some profit if an opportunity exists. 
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The range of drug supply practices that may be defined as social supply includes sharing, swapping, 
‘gift giving’, group buying and ‘chipping in’ (combining money to buy drugs as a group) (Coomber 
et al. 2018). Social supply has traditionally been associated with cannabis, but recent international 
evidence suggests it now also extends to small-scale distribution of other illicit substances such as 
ecstasy, cocaine, methamphetamine and ketamine (Coomber et al. 2018). Friends and family are 
also a common source of pharmaceutical drugs for non-medical use (Hulme, Bright & Nielsen 2018; 
Hulme, Hughes & Nielsen 2019).
Drugs research has identified various factors that may explain the prominence of social supply 
activities. Social supply occurs at a reduced cost to the user and as such can be a cost-effective and 
convenient way to acquire drugs (Coomber, Moyle & South 2015; Potter 2009). Notions of reciprocity 
can also mean that drug users ‘take turns’ supplying drugs to each other, leading them to get involved 
in social supply on behalf of their social groups to ‘return the favour’ (Coomber, Moyle & South 
2015). Another important aspect of social supply is trust in the supplier and their drugs, reducing 
the perceived likelihood of the drugs being low quality and unsafe (Coomber, Moyle & South 2015; 
Murphy et al. 2004; Taylor & Potter 2013). Related to this sense of trust is a perception that social 
supply reduces risk for drug market participants because it insulates them from police intervention 
and legal repercussions (Potter 2009). Additionally, social supply has been viewed as establishing a 
buffer between users and ‘real dealers’ (Parker 2000). Finally, the social aspect of this form of supply 
is key to involvement in the activity, with supply transactions being important among friendship 
groups (Coomber, Moyle & South 2015). 
Aim
This study aims to explore the social supply of pharmaceutical opioids and identify factors that may 
predict the use of social supply to source these drugs. We also aim to explore why people who use 
illicit pharmaceutical opioids prefer to acquire them via social supply.
Method
This study analyses data from the Drug Use Monitoring in Australia (DUMA) program. DUMA collects 
sociodemographic, drug use and offending history information from people detained at police stations 
or watch houses and who agree to take part in the program. These individuals are often directly 
involved in drug markets and other criminal activity and they account for a disproportionate level of 
drug use and its associated harm. For example, an earlier study found that almost one-fifth of police 
detainees had engaged in non-medical use of prescription opioids (Sullivan, Ticehurst & Bricknell 
2018), far more than the 3.6 percent of the general population who misuse painkillers, analgesics or 
opioids (Australian Institute of Health and Welfare 2017).
For this study, an addendum questionnaire about pharmaceutical opioid use collected data from 
1,195 respondents detained in January–February or April–May 2018. Respondents were detained at 
police stations or watch houses in Adelaide, Brisbane, Perth, and Bankstown and Surry Hills in Sydney. 
The sample comprised 83 percent men (n=987) and 17 percent women (n=208). The median age was 
33 years (mean=34 years), ranging from 18 to 77 years. Seventy-five percent (n=897) of the sample 
was non-Indigenous.
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The addendum asked respondents whether they had used the following pharmaceutical opioids in the 
past 12 months: buprenorphine, methadone, morphine, oxycodone, fentanyl, pethidine, tramadol 
and codeine. Respondents who in the last 12 months had used only codeine or used codeine more 
frequently than other opioids (n=195) were excluded because they were not within the scope of this 
study’s focus on higher risk pharmaceuticals and also because codeine’s legal status changed during 
the collection period. 
For each opioid type respondents had used in the past 12 months, the addendum also included 
questions about age of first use and why respondents had started to use the drug. Respondents who 
had used only one opioid type in the past 12 months were asked a series of questions about their 
acquisition and use of that opioid. Those who had used multiple opioid types were asked the same 
questions about the opioid they had used most frequently in the past 12 months.
The analysis of social supply was limited to respondents who reported using a drug for non-medical 
purposes or without a prescription. Based on the research literature, the study defined social supply 
as acquiring pharmaceutical opioids from a family member or friend, either without paying cash or by 
swapping the opioids for other drugs. We acknowledge that some researchers also include buying drugs 
from a family member or friend in their definition of social supply (Coomber et al. 2018). However, we 
could not identify whether those detainees who bought from a family member or friend—who did not 
also receive them for free or swap them (n=17)—were involved in a commercial transaction. 
The study focused on the sourcing rather than diversion of pharmaceutical opioids through 
social supply activities because the addendum was limited to questions about the acquisition of 
pharmaceutical opioids. To better understand social supply, we examined the demographic and drug 
use characteristics of those who used this form of supply. 
Results
Pharmaceutical opioid use
Twenty-three percent (n=229) of the sample reported having used at least one type of 
pharmaceutical opioid in the past 12 months, including prescribed and non-prescribed opioids. 
Twenty-three percent of female respondents (n=39) and male respondents (n=190) had used 
pharmaceutical opioids in the past 12 months. Similar proportions of Indigenous and non-Indigenous 
detainees reported using opioids in the past 12 months (20%, n=54; 24%, n=174). The leading opioids 
detainees had used in the last 12 months were buprenorphine (31%, n=71), tramadol (21%, n=48), 
oxycodone (18%, n=42) and methadone (15%, n=35).
Fifty percent of respondents who had used opioids had used them for non-medical purposes 
(n=115)—10 percent of the overall sample. More than half of the respondents who had used 
morphine (68%, n=13), buprenorphine (66%, n=47) and fentanyl (83%, n=5) reported non-medical 
use of these drugs (see Figure 1).
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a: Includes Suboxone, a combination medication containing buprenorphine and naloxone 
b: Includes dextropropoxyphene, hydromorphone and other drugs not specified by the respondent
c: Includes pethidine
Source: AIC DUMA collection 2018 [computer file]
Of those who had used pharmaceutical opioids for non-medical purposes and who responded to 
questions about their availability (n=104), 31 percent (n=32) reported pharmaceutical opioids were 
very easy to get without a prescription, 43 percent (n=45) reported it was easy, 17 percent (n=18) 
reported it was hard and nine percent (n=9) reported it was very hard.
Methods of acquisition
Respondents were asked to nominate any method they had used to acquire pharmaceutical opioids 
for non-medical use in the past 12 months. Seventy-seven respondents (67%) had used one method 
and 38 (33%) had used more than one method. Two respondents reported using social supply methods 
even though they had not used a pharmaceutical opioid without a prescription in the past 12 months, 
and were excluded from the social supply analysis. The leading form of social supply was receiving 
opioids from a family member or friend without paying cash (57%, n=64), while 12 percent (n=13) 
swapped other drugs for them. By comparison, a third (34%, n=38) of non-medical users had bought 
pharmaceutical opioids from a dealer and almost one in three (30%, n=34) had bought them from a 
family member or friend. Smaller numbers of respondents deceived medical professionals or bought 
from the internet to obtain opioids for non-medical use (see Table 1).
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Table 1: Methods of acquiring opioids for non-medical use
n %
Received from family or friends 64 56.6 
Swapped 13 11.5
Social supply 69 61.1
Bought from family member or friend 34 30.1
Bought from dealer 38 33.6
Bought from the internet 3 2.7
Stole 5 4.4
Doctor shopping 3 2.7
Lied to a doctor 3 2.7
Prescription in someone else’s name 8 7.1
Other 11 9.7
No method specified 1 0.9
Total respondents acquiring opioids for non-medical use 113
Note: Respondents could report more than one method
Source: AIC DUMA collection 2018 [computer file]
Social supply was the most common method of acquiring each type of opioid. More than half of 
respondents who had used any of the six pharmaceutical opioids for non-medical purposes in the 
previous 12 months had received the drug from a family member or friend or swapped other drugs 
for them. For each type of drug (excluding ‘Other opioids’), at least 55 percent of non-medical users 
had sourced their opioids through social supply (see Figure 2).
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a: Includes Suboxone, a combination medication containing buprenorphine and naloxone
b: Method of acquisition data was missing for one record 
c: Includes all opioids listed plus dextropropoxyphene, hydromorphone and other drugs not specified by the respondent
Source: AIC DUMA collection 2018 [computer file]
Reasons for using pharmaceutical opioids
Respondents who had acquired pharmaceutical opioids for non-medical use through social supply 
and those who used other methods had begun using these drugs for different reasons. More than 
two-thirds (68%, n=17) of non-medical users who had started using opioids because they were 
prescribed them for medical reasons had obtained their drugs through social supply. In contrast, 
just over half (54%, n=13) of those who had started using pharmaceutical opioids as a substitute for 
heroin had obtained them through social supply (see Figure 3).
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Note: Respondents could provide more than one reason for starting pharmaceutical opioid use
Source: AIC DUMA collection 2018 [computer file]
Age was not a predictor of preference for social supply activities. Fifty-five percent of non-medical 
pharmaceutical opioid users aged 36 years and over preferred social supply to other methods (n=16). 
Similarly, 54 percent (n=22) of non-medical users aged 35 years and under preferred social supply. 
However, some older respondents who preferred social supply methods had different pathways into 
non-medical opioid use than younger respondents. Among the older age group, 31 percent (n=5) of 
respondents who preferred social supply had begun to use pharmaceutical opioids because they 
were a substitute for heroin, compared with 23 percent (n=5) of the younger respondents who 
preferred social supply. 
Respondents who preferred social supply methods used pharmaceutical opioids slightly less 
frequently than those preferring other methods. Forty-seven percent (n=18) of those preferring 
social supply methods used pharmaceutical opioids for non-medical purposes monthly or more 
frequently, compared with 56 percent (n=18) of those who preferred other methods. Frequent users 
of pharmaceutical opioids who preferred social supply methods tended to be older (median age=33, 
mean=33) than frequent users who preferred other methods (median age=28, mean=31).
Non-medical pharmaceutical opioid users reported preferring social supply mainly because it was a 
convenient and economical way to acquire the drugs. A smaller number of respondents preferred to 
use social supply methods because they involved reciprocal exchanges, greater certainty about the 
product they were receiving, and fewer risks than other methods. 
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Conclusion
More than half of the police detainees who had used pharmaceutical opioids for non-medical 
purposes in the past 12 months had accessed these drugs through social supply. Almost all of these 
individuals had sourced the opioids from family and friends for free, and a smaller number had 
swapped other drugs for them. A substantial proportion of detainees also bought pharmaceutical 
opioids from family and friends. 
These findings are consistent with the results of a recent meta-analysis of empirical studies of 
the non-medical use of pharmaceutical drugs, which suggested 57 percent of people sourced 
pharmaceutical drugs from friends or family without paying (Hulme, Bright & Nielsen 2018).  
Police detainees have also reported that they commonly buy or get methamphetamine for free 
from relatives and friends, and that many use ‘closed’ markets, such as a friend’s home, rather than 
public ‘open’ markets (Doherty forthcoming). Other research has suggested that social supply is also 
important in the markets for cannabis (Belackova & Vaccaro 2013; Lenton et al. 2015; Nicholas 2008) 
and ecstasy (Bright & Sutherland 2017; Nicholas 2008). Friendship groups appear to play a smaller 
role in the distribution of heroin, which is more commonly sold by dealers in open markets (Mouzos 
et al. 2007; Nicholas 2008). 
Respondents who preferred social supply methods of obtaining pharmaceutical opioids for non-medical 
use tended to consume the drugs slightly less frequently than others. The lower frequency of use by 
respondents preferring social supply may suggest these individuals are at less risk of harmful patterns 
of drug use than those relying on sources such as buying from drug dealers.
This study also extended previous research by asking detainees why they preferred to acquire 
pharmaceutical opioids via social supply. The findings suggested these methods were appealing 
primarily because of convenience and the absence of any financial cost. These results correspond 
with research suggesting that forms of social supply can be cost-effective and convenient methods 
of accessing illicit drugs (Bright & Sutherland 2017; Coomber, Moyle & South 2015; Potter 2009). 
The restricted availability and variable pricing of illicit pharmaceutical opioids relative to other illicit 
drugs may contribute to the desire to use social supply activities to acquire these drugs. Research 
suggests people who use illicit pharmaceutical opioids such as oxycodone and buprenorphine find 
it more difficult to obtain these drugs than heroin users seeking to obtain heroin (Karlsson & Burns 
2018; Stafford & Breen 2017). The price of pharmaceutical opioids such as oxycodone can also vary 
(Karlsson & Burns 2018), potentially motivating users to source them for free from relatives or friends 
to avoid unpredictable costs. In contrast, surveys of injecting drug users suggest the price of a ‘cap’  
(a single injection) of heroin has been $50 for several years, albeit at varying levels of purity (Karlsson 
& Burns 2018). Individuals who use social supply activities may also be socialising with people who 
have access to pharmaceutical opioids through opioid substitution therapy or other treatment 
services (Hulme, Bright & Nielsen 2018). 
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A smaller number of detainees reported that they preferred social supply methods for the reciprocity. 
Drugs research has identified ‘cultures of reciprocity’ among people involved in social supply 
activities, which involve sharing drugs for free and giving them as gifts to friends (Coomber, Moyle & 
South 2015). Small numbers of respondents also reported sourcing pharmaceutical opioids via social 
supply to improve the likelihood the drug was of good quality and quantity, to reduce the risk of 
getting adulterated drugs and to avoid other risks associated with illicit drug markets. 
Coomber, Moyle and South (2015) suggest the distance that normally law-abiding individuals need 
to slip or ‘drift’ (Matza 2009) to get involved in the social supply of recreational drugs is much shorter 
than for ‘hard drugs’, because recreational drugs are more socially acceptable. Our study suggests 
that pharmaceuticals used for non-medical purposes represent a third category, considered more 
socially acceptable than recreational or hard drugs because they also have legal uses. The acquisition 
and supply of these pharmaceuticals for non-medical use may therefore require an even smaller 
slip into illegal behaviour than the social supply of recreational drugs. This is supported by general 
population data suggesting 28 percent of Australians perceive the misuse of pharmaceuticals as 
acceptable, a higher proportion than for other drugs such as cannabis and methamphetamine 
(Australian Institute of Health and Welfare 2019).
Limitations
This study is unable to make causal claims because of its cross-sectional design. In addition, the 
study’s definition of non-medical use is likely to differ from those used in other research. While 
this study focused on the use of pharmaceutical opioids without a prescription or for ‘non-medical 
purposes’, other research has defined non-medical use as ‘use for non-therapeutic purposes’ or 
‘other than directed by a healthcare professional’ (Hulme, Bright & Nielsen 2018). This limitation 
draws attention to the importance of having a standardised definition of non-medical use. Further, 
the sample of police detainees included in this analysis is not necessarily representative of all 
arrestees in Australia. For example, the study excluded detainees with certain characteristics, such as 
a high levels of intoxication. The study was also limited to an analysis of the sourcing rather than the 
diversion of pharmaceutical opioids.
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